145 related articles for article (PubMed ID: 38042231)
1. EXPLORing the Therapeutic Ceiling in Crohn's Disease: Will Combination Pave the Way?
Torres J; Hanauer SB
Clin Gastroenterol Hepatol; 2024 Jul; 22(7):1377-1378. PubMed ID: 38042231
[No Abstract] [Full Text] [Related]
2. [Therapy of Crohn's disease in childhood].
Harms HK; Bertele RM
Monatsschr Kinderheilkd; 1981 Mar; 129(3):139-42. PubMed ID: 6112679
[No Abstract] [Full Text] [Related]
3. Medical management: its accomplishments in Crohn's disease and indications for surgery.
Allan RN
World J Surg; 1988 Apr; 12(2):174-9. PubMed ID: 2899366
[No Abstract] [Full Text] [Related]
4. Hidradenitis suppurativa and Crohn's disease: two cases that support an association.
Yazdanyar S; Miller IM; Jemec GB
Acta Dermatovenerol Alp Pannonica Adriat; 2010 Oct; 19(3):23-5. PubMed ID: 20976417
[TBL] [Abstract][Full Text] [Related]
5. Treatment of severe Crohn's disease using antimycobacterial triple therapy--approaching a cure?
Borody TJ; Leis S; Warren EF; Surace R
Dig Liver Dis; 2002 Jan; 34(1):29-38. PubMed ID: 11926571
[TBL] [Abstract][Full Text] [Related]
6. Remission maintained by monotherapy after biological + immunosuppressive combination for Crohn's disease in clinical practice.
Ampuero J; Rojas-Feria M; Castro-Fernández M; Millán-Lorenzo M; Guerrero-Jiménez P; Romero-Gómez M
J Gastroenterol Hepatol; 2016 Jan; 31(1):112-8. PubMed ID: 26173493
[TBL] [Abstract][Full Text] [Related]
7. Vedolizumab, Adalimumab, and Methotrexate Combination Therapy in Crohn's Disease (EXPLORER).
Colombel JF; Ungaro RC; Sands BE; Siegel CA; Wolf DC; Valentine JF; Feagan BG; Neustifter B; Kadali H; Nazarey P; James A; Jairath V; Qasim Khan RM
Clin Gastroenterol Hepatol; 2024 Jul; 22(7):1487-1496.e12. PubMed ID: 37743037
[TBL] [Abstract][Full Text] [Related]
8. Crohn's Disease after Proctocolectomy and IPAA for Ulcerative Colitis.
Hercun J; Côté-Daigneault J; Lahaie RG; Richard C; Wassef R; Poitras P
Dis Colon Rectum; 2021 Feb; 64(2):217-224. PubMed ID: 33315714
[TBL] [Abstract][Full Text] [Related]
9. Case report: combination therapy with granulocyte apheresis and infliximab for refractory Crohn's disease.
González Carro P; Pérez Roldán F; Roncero García Escribano O; Lafuente R; Legaz Huidobro ML; Amigo Echenagusía A
J Clin Apher; 2006 Dec; 21(4):249-51. PubMed ID: 16607627
[No Abstract] [Full Text] [Related]
10. Top-down in the Long Term in Crohn's Disease.
Boyapati RK; Ho GT; Satsangi J
J Crohns Colitis; 2018 Apr; 12(5):513-514. PubMed ID: 29548025
[No Abstract] [Full Text] [Related]
11. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine.
Egan LJ; Sandborn WJ; Tremaine WJ
Am J Gastroenterol; 1998 Mar; 93(3):442-8. PubMed ID: 9517654
[TBL] [Abstract][Full Text] [Related]
12. Comparison of enteral nutrition and drug treatment in active Crohn's disease: results of the European Cooperative Crohn's Disease Study IV.
Demetriou AA
JPEN J Parenter Enteral Nutr; 1992; 16(1):84-5. PubMed ID: 1346656
[No Abstract] [Full Text] [Related]
13. Therapy of Crohn's disease in childhood.
Walker-Smith JA
Baillieres Clin Gastroenterol; 1997 Sep; 11(3):593-610. PubMed ID: 9448917
[TBL] [Abstract][Full Text] [Related]
14. Antimycobacterial therapy for Crohn's disease.
Gilad J
Am J Gastroenterol; 2000 Oct; 95(10):2985-6. PubMed ID: 11051386
[No Abstract] [Full Text] [Related]
15. [Adalimumab for Crohn's disease. Monotherapy or combination therapy? -Discussion with results from DIAMOND study].
Hisamatsu T; Saito D; Ozaki R
Nihon Shokakibyo Gakkai Zasshi; 2019; 116(3):193-199. PubMed ID: 30853671
[No Abstract] [Full Text] [Related]
16. What is the optimal maintenance treatment for Crohn's disease?
Seibold F
Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S255-6. PubMed ID: 18816744
[No Abstract] [Full Text] [Related]
17. Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study.
Kennedy NA; Heap GA; Green HD; Hamilton B; Bewshea C; Walker GJ; Thomas A; Nice R; Perry MH; Bouri S; Chanchlani N; Heerasing NM; Hendy P; Lin S; Gaya DR; Cummings JRF; Selinger CP; Lees CW; Hart AL; Parkes M; Sebastian S; Mansfield JC; Irving PM; Lindsay J; Russell RK; McDonald TJ; McGovern D; Goodhand JR; Ahmad T;
Lancet Gastroenterol Hepatol; 2019 May; 4(5):341-353. PubMed ID: 30824404
[TBL] [Abstract][Full Text] [Related]
18. Adalimumab and Azathioprine Combination Therapy for Crohn's Disease: A Shining Diamond?
Fiorino G; Danese S
J Crohns Colitis; 2016 Nov; 10(11):1257-1258. PubMed ID: 27389085
[No Abstract] [Full Text] [Related]
19. Defining the phenotype, pathogenesis and treatment of Crohn's disease associated spondyloarthritis.
Kumar A; Lukin D; Battat R; Schwartzman M; Mandl LA; Scherl E; Longman RS
J Gastroenterol; 2020 Jul; 55(7):667-678. PubMed ID: 32367294
[TBL] [Abstract][Full Text] [Related]
20. Thiopurines and their optimization during infliximab induction and maintenance: A retrospective study in Crohn's disease.
Luber RP; Dawson L; Munari S; Kariyawasam VC; Martin C; Gibson PR; Sparrow MP; Ward MG
J Gastroenterol Hepatol; 2021 Apr; 36(4):990-998. PubMed ID: 32881046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
